Literature DB >> 12368654

Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism.

Birte Svensson1, Marion Peters, Hans-Georg König, Monika Poppe, Bodo Levkau, Matthias Rothermundt, Volker Arolt, Donat Kögel, Jochen H M Prehn.   

Abstract

The authors investigated the effect of vascular endothelial growth factor (VEGF) on hypoxic injury of cultured rat hippocampal neurons. Treatment with glutamate receptor antagonists prevented hypoxic neuron death. The same magnitude of protection was observed in cultures treated with VEGF, which also reduced excitotoxic neuron death induced directly by an exposure to -methyl-d-aspartate. Vascular endothelial growth factor did not alter the activation of the transcription factor nuclear factor-kappaB during hypoxia and protected cells in a PI-3-kinase-independent manner. Vascular endothelial growth factor failed to protect against staurosporine-induced, caspase-dependent apoptosis. These data suggest that VEGF-induced protection against hypoxic injury primarily involves the inhibition of excitotoxic processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368654     DOI: 10.1097/01.wcb.0000037988.07114.98

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  41 in total

Review 1.  Gene and protein therapies utilizing VEGF for ALS.

Authors:  Orion P Keifer; Deirdre M O'Connor; Nicholas M Boulis
Journal:  Pharmacol Ther       Date:  2013-10-29       Impact factor: 12.310

2.  17β-estradiol increases astrocytic vascular endothelial growth factor (VEGF) in adult female rat hippocampus.

Authors:  Sharon Barouk; Tana Hintz; Ping Li; Aine M Duffy; Neil J MacLusky; Helen E Scharfman
Journal:  Endocrinology       Date:  2011-02-22       Impact factor: 4.736

3.  Dose-dependent neuroprotection of VEGF₁₆₅ in Huntington's disease striatum.

Authors:  Stuart M Ellison; Antonio Trabalza; Veronica Tisato; Evangelos Pazarentzos; Shirley Lee; Vasiliki Papadaki; Despoina Goniotaki; Sarah Morgan; Nazanin Mirzaei; Nicholas D Mazarakis
Journal:  Mol Ther       Date:  2013-06-25       Impact factor: 11.454

Review 4.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

5.  Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum.

Authors:  Subramaniam Jayanthi; Michael T McCoy; Genevieve Beauvais; Bruce Ladenheim; Kristi Gilmore; William Wood; Kevin Becker; Jean Lud Cadet
Journal:  PLoS One       Date:  2009-06-30       Impact factor: 3.240

Review 6.  Vascular endothelial growth factors (VEGFs) and stroke.

Authors:  David A Greenberg; Kunlin Jin
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

Review 7.  Vascular endothelial growth factor: a neurovascular target in neurological diseases.

Authors:  Christian Lange; Erik Storkebaum; Carmen Ruiz de Almodóvar; Mieke Dewerchin; Peter Carmeliet
Journal:  Nat Rev Neurol       Date:  2016-07-01       Impact factor: 42.937

8.  Iba1(+)/NG2(+) macrophage-like cells expressing a variety of neuroprotective factors ameliorate ischemic damage of the brain.

Authors:  Anna Smirkin; Hiroaki Matsumoto; Hisaaki Takahashi; Akihiro Inoue; Masahiko Tagawa; Shiro Ohue; Hideaki Watanabe; Hajime Yano; Yoshiaki Kumon; Takanori Ohnishi; Junya Tanaka
Journal:  J Cereb Blood Flow Metab       Date:  2009-10-28       Impact factor: 6.200

9.  Effect of VEGF treatment on the blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Chirag B Patel; David M Cohen; Pallavi Ahobila-Vajjula; Laura M Sundberg; Tessy Chacko; Ponnada A Narayana
Journal:  J Neurotrauma       Date:  2009-07       Impact factor: 5.269

10.  Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K/Akt and/or MEK/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine.

Authors:  Jennifer M Laing; Cynthia C Smith; Laure Aurelian
Journal:  J Neurochem       Date:  2009-11-05       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.